Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Auckland Clinical Studies Ltd, Grafton

Translational Research Centre, Darlinghurst

Royal Prince Alfred Hospital, Camperdown

Christchurch Clinical Studies Trust, Ltd, Christchurch

NYU Langone Medical Center, New York

Columbia University Medical Center/ New York Presbyterian, New York

Leber- and Studienzentrum am Checkpoint, Berlin

Center for Liver Diseases, Oakland, Pittsburgh

Gastrointestinal Specialists of Georgia, Marietta

Emory Hospital Midtown Infectious Disease Clinic, Atlanta

Orlando Immunology Center, Orlando

New Orleans Center for Clinical Research, Knoxville

Gastro One, Germantown

Universitatsklinikum Bonn, Bonn

Saint Louis University, Gastroenterology & Hepatology, Clinical Research Unit, St Louis

Centre Hospitalier Universitaire de Rouen, Rouen

University of Colorado Denver (Leprino Building), Aurora

Ruane Clinical Research Group Inc., Los Angeles

Cedars Sinai Medical Center, Los Angeles

Kaiser Permanente, San Diego

Inland Empire Liver Foundation, Rialto

Stanford Hospital and Clinics, Palo Alto

University of Washington/Harborview Medical Center, Seattle

University Gastroenterology, Providence

Kay Edmonton Clinic, Edmonton

Toronto Centre for Liver Disease (TCLD), Toronto General Hospital, Toronto

Kings College Hospital NHS Trust, London